Sonoma Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DRW SECURITIES, LLC | 02/12/2026 | 60.98 K | $221.96 K | 257.22% | 3.56% |
| VANGUARD GROUP INC | 01/29/2026 | 18.89 K | $68.75 K | -9.51% | 1.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 15.91 K | $57.91 K | -9.70% | 0.93% |
| MCKINLEY CARTER WEALTH SERVICES, INC. | 02/06/2026 | 11.19 K | $40.74 K | 100.00% | 0.68% |
| GLOBAL RETIREMENT PARTNERS, LLC | 02/06/2026 | 772 | $2.81 K | 76.26% | 0.05% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 500 | $1.82 K | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 385 | $1.40 K | -74.93% | 0.02% |
| JPMORGAN CHASE & CO | 02/11/2026 | 121 | $440 | -1.63% | 0.01% |
| BLACKROCK, INC. | 02/12/2026 | 113 | $411 | 0.00% | 0.01% |
| US BANCORP \DE\ | 01/30/2026 | 25 | $91 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 18 | $65 | 5.88% | 0.00% |
| UBS GROUP AG | 01/29/2026 | 6 | $22 | -94.44% | 0.00% |
| MORGAN STANLEY | 02/13/2026 | 4 | $15 | 0.00% | 0.00% |
| QUAKER WEALTH MANAGEMENT, LLC | 01/28/2026 | 3 | $11 | 0.00% | 0.00% |
| DANSKE BANK A/S | 02/02/2026 | 1 | $4 | 0.00% | 0.00% |
| FMR LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 02/05/2026 | 0 | $0 | -100.00% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 03/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 0 | $0 | -100.00% | 0.00% |
Sonoma Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 22 institutional investors and hedge funds held shares of Sonoma Pharmaceuticals Inc.. The most heavily invested institutionals were:
McKinley Carter Wealth Services, Inc.: 11,193
Quaker Wealth Management, LLC: 3
DRW Securities, LLC: 60,977
VANGUARD GROUP INC: 18,887
GEODE CAPITAL MANAGEMENT, LLC: 15,908
Global Retirement Partners, LLC: 772
6.36% of Sonoma Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 111.35 K shares in the last 24 months. This purchase volume represents approximately $280.59 K in transactions.